Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome
- Conditions
- Amyloidosis CardiacCarpal Tunnel Syndrome
- Interventions
- Diagnostic Test: DPD Scintigraphy
- Registration Number
- NCT03996382
- Lead Sponsor
- Aarhus University Hospital Skejby
- Brief Summary
Wild-type transthyretin cardiac amyloidosis is an underdiagnosed depository disease in which fibril monomers of misfolded amyloid protein accumulates in various tissues, including the heart, and cause tissue dysfunction.
Before onset of cardiac symptoms, many patients will have undergone surgery for idiopathic carpal tunnel syndrome since the protein also deposits in the transversal carpal ligament of the hand.
This study investigates patients previously operated for idiopathic carpal tunnel syndrome to determine if they display signs and symptoms of cardiac amyloidosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
- Patients above sixty years of age previously operated for idiopathic carpal tunnel syndrome within the Region of Central Denmark (Region Midtjylland) the last five years.
- Informed written and verbal consent
-
Operation by different indication such as
- Fracture
- Ganglion
- Tumors
- Osteophytes
- Rheumatoid Arthritis
- Persistent medial artery
- Metabolic causes
-
Alcoholism
-
Hyperthyroidism
-
Myxedema
- Hereditary Cardiac Amyloidosis
- Known WT ATTR
- AL Amyloidosis
- Myelomatosis
- MGUS and Morbus Waldenström
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Suspicion of cardiac amyloidosis DPD Scintigraphy Patients who display signs of cardiac amyloidosis will be referred for further diagnosis.
- Primary Outcome Measures
Name Time Method Prevalence of cardiac amyloidosis. Through study completion, an average of 2 years. The prevalence of cardiac amyloidosis among patients previously operated for ipiopathic carpal tunnel syndrome.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of Heart Disease
🇩🇰Aarhus, Denmark